Clinical Trial Update: Trial Of Paricalcitol and Cholecalciferol(Vitamin D3) in the Treatment Of Secondary Hyperparathyroidism in Patients After ROUX-EN-Y Gastric Bypass Surgery [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated paricalcitol plus cholecalciferol for secondary hyperparathyroidism in patients after Roux-en-Y gastric bypass; the study completed wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperparathyroidism

Drugs mentioned

• Cholecalciferol (Vitamin D3)
• Zemplar (paricalcitol) (paricalcitol)

Snippet

Sponsor: Kerstyn C. Zalesin, M.D. | Conditions: Gastric Bypass, Parathyroid Hormone | Phase 3 | Status: COMPLETED | Results posted: 2017-03-22